Join the University of Chicago’s Christine Drogan, a Licensed Certified Genetic Counselor, and Dr. Bradford Chong, Director of the Pancreas Program, for November’s Wellness Wednesday. Learn how you can take part in the Pancreatic Cancer Early Detection (PRECEDE) Consortium global study focused on improving Pancreatic Cancer early detection and outcomes! The PRECEDE Consortium is a group of experts from different institutions worldwide. Their mission is to help find Pancreatic Cancer sooner, especially in people with a higher inherited risk. They do this by finding better ways to screen, predict, and prevent Pancreatic Cancer through shared research and collaboration. Key Takeaways: - Find out how easy it is to participate in the study—just an annual blood draw! - Understand why it is important to join the already 7,000 PRECEDE study participants. - Learn about PRECEDE's efforts to improve early detection and increase survival rates from 10% to 50% in 10 years. - Understand how PRECEDE’s approach to screening and risk modeling is different and can make a big impact. Whether you have a family history of Pancreatic Cancer or just want to learn more, this session is for you! To learn more about PRECEDE and their study, visit: https://precedestudy.org/?fbclid=IwY2xjawGrFytleHRuA2FlbQIxMAABHaczed63cA7FM2EiQ0u0xUR-nVNePTgiKYlZxPorvD_tV75ZPFlBU3VKIA_aem_e4VhYWa7k2KOK_OBHiWCBQ